期刊文献+

跨膜蛋白活化物及钙调亲环素配体相互作用分子在狼疮肾炎患者外周血中的表达及其临床意义 被引量:1

Expression of TACI in patients with lupus nephritis
暂未订购
导出
摘要 目的研究狼疮肾炎(lupus nephritis,LN)患者跨膜蛋白活化物及钙调亲环素配体相互作用分子(TACI)的表达及其与疾病活动度的关系。方法分别采用逆转录实时荧光定量聚合酶链反应(FQ-RT-PCR)方法,检测42例LN患者,30例非LN患者,40例健康体检者外周血单个核细胞(PBMC)TACI mRNA表达水平;采用流式细胞术(FCM)检测外周血B淋巴细胞表面TACI表达百分率;采用酶联免疫吸附测定(ELISA)检测血清中抗双链DNA抗体(dsDNA)水平;采用速率散射比浊法检测血清中补体C3的水平。结果①LN组非LN组和和健康对照组TACI mRNA表达水平分别为:6.07±0.46,7.73±0.60和8.02±0.51。LN组TACI mRNA表达水平高于非LN组及健康对照组;非LN组TACI mRNA表达水平高于健康对照组(P<0.01)。②LN组、非LN组和健康对照组B淋巴细胞表面TACI表达百分率分别为:(7.95±1.58)%,(3.98±1.29)%和(2.87±0.56)%。LN组B淋巴细胞表面TACI表达百分率显著高于非LN组和健康对照组;非LN组高于健康对照组(P<0.01)。③LN患者PBMC中TACI mRNA的表达水平与抗dsDNA抗体呈显著正相关(r=0.312,P<0.05);与补体C3呈显著负相关(r=-0.315,P<0.05)。结论 LN患者TACI表达水平升高,可能参与了LN的发病过程;治疗后TACI表达水平降低,减轻炎症损害,可能成为评价疗效和预后的新指标。 Objective The objective of this study was to explore the association between the expression of transmembrane activator and calcium modulator and cyclophilin ligand interactor(TACI) receptor in patients with lupus nephritis(LN). Methods Reverse transcription-real time quantitative polymerase chain reaction(FQ-RT-PCR) was used to examine TACI mRNA expression in peripheral blood monocytes of 42 cases of LN,30 cases in non-LN,and 40 healthy controls. TACI receptor percentage on B lymphocytes was measured by flow cytometry(FCM). The anti- dsDNA antibody level in serum was assayed by ELISA. The serum complement C3 level was assayed by automatic immune analysis machine. Results (1)The TACI mRNA level in patients with LN,n0n-LN group and normal controls was 6.07±0.46,7.73±0.60 and 8.02±0.51. The TACI mRNA level in patients with LN was higher than that of non-LN group and normal controls, the TACI of non-LN group was higher than that of normal controls, there were significant difference among three groups( P 〈0.01). (2)The percentage of TACI on B lymphocytes in patients with LN, non-LN group and normal controls was (7.95 ±1.58)%, (3.98± 1.29)% and (2.87± 0.56)%. The percentage of TACI on B lymphocytes in patients with LN was higher than that of non-LN group and normal controls,the percentage of non-LN group was higher than that of normal controls,there were significant differences among three groups( P 0.01). QThe expression level of TACI mRNA in PBMC of patients with LN was correlated significantly with the titers of anti-dsDNA antibody ( r =0. 312, P d0.05) and serum complement C3 level ( r =-0. 315, P 〈0.05). Conclusion This study suggests that TACI may be involved in the development of LN the level of TACI may be a valuable parameter for evaluating the treatment.
出处 《临床荟萃》 CAS 2013年第2期141-143,147,共4页 Clinical Focus
关键词 狼疮肾炎 白细胞 单核 生物学标记 lupus nephritis leukocytes, mononuclear biologiceal markers
  • 相关文献

参考文献13

  • 1Bhat P,Radhakrishnan J. B lymphocytes and lupus nephritis:new insights into pathogenesis and targeted therapies[J].Kidney International,2008,(03):261-268.
  • 2Castigli E,Wilson SA,Scott S. TACI and BAFF-R mediate isotype switching in B cells[J].Journal of Experimental Medicine,2005,(01):35-39.
  • 3Ozcan E,Rauter I,Garibyan L. Toll-like receptor 9,transmembrane activator and calcium-modulating cyclophilin ligand interactor,and CD40 synergize in causing B-cell activation[J].Journal of Allergy and Clinical Immunology,2011,(03):601-609.
  • 4Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J].Arthritis and Rheumatism,1997,(09):1725.
  • 5Chang A,Henderson SG,Brandt D. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis[J].Journal of Immunology,2011,(03):1849-1860.
  • 6李桂英,燕霞,佘红艳,李玲,王春来,李英.长春新碱环磷酰胺序贯治疗对狼疮肾炎患者外周血B淋巴细胞活化因子表达的影响[J].临床荟萃,2012,27(11):933-936. 被引量:6
  • 7Fairfax K,Mackay IR,Mackay F. BAFF/BLyS inhibitors:a new prospect for treatment of systemic lupus erythematosus[J].IUBMB Life,2012,(07):595-602.
  • 8Treml LS,Carlesso G,Hoek KL. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells[J].Journal of Immunology,2007,(12):7531-7539.
  • 9Fu L,Lin-Lee YC,Pham LV. BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells[J].Blood,2009,(19):4627-4636.
  • 10Groom JR,Fletcher CA,Walters SN. BAFF and MyD88 signals promote a lupuslike disease independent of T cells[J].Journal of Experimental Medicine,2007,(08):1959-1971.

二级参考文献12

  • 1侯广慧,李小峰,魏华,赵文鹏.周期联合免疫抑制剂对cGVHD狼疮样小鼠单核细胞趋化蛋白-1的影响[J].中国药物与临床,2008,8(S2):3-5. 被引量:2
  • 2D'eruz DP, Houssiau FA. The euro-lupus nephritis trial: the development of the sequential treatment protocol[J]. Lupus, 2009,18(10) : 875-877.
  • 3Karim MY, Pisoni CN, Khamashta MA. Update immunotherapy for systemic lupus erythematosus-what' s hot and what's not! [J] Rheumatology,2009,48(1) ..332-341.
  • 4Parameswaran R,David HB, Sharabi A, et al. B-cell activating factor( BAFF ) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus[J]. Clin lmmunol, 2009,131 (2) .. 223-232.
  • 5Carrie AF, Joanna RG, Blanche W, et al. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice [J]. J Autoimmun, 2011,36(2) :125-134.
  • 6Chan TM. Treatment of membranous lupus nephritis with nephritic syndrome by sequential immunosuppression [J ]. Lupus, 1999,8(7) :545-551.
  • 7王晨丹.根据细胞周期序贯联合免疫抑制剂对肾小球疾病的影响[D].山西医科大学,2012.
  • 8李桂英 刘淑霞 路新卿 等.狼疮平颗粒对BXSB狼疮肾炎小鼠血清和B淋巴细胞BAFF表达的影响.中国中西医结合杂志,32(3):357-360.
  • 9刘小军.长春新碱联合低剂量环磷酰胺治疗系统性红斑狼疮临床评价及对BAFF和BAFF-R影响研究[D].山西医科大学,2012.
  • 10Sanz I, Lee FE. B cells as therapeutic targets in SLE[J]. Nat Rev Rheumatol,2010,6(6) :326-337.

共引文献5

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部